GATA-4, a transcription factor implicated in lineage determination, is expressed in both parietal and visceral endoderm of the early mouse embryo. In embryonic stem cell-derived embryoid bodies, GATA-4 mRNA is first detectable at 4-5 days of differentiation and is confined to visceral endoderm cells on the surface of the bodies. Previously we reported that targeted mutagenesis of the Gata4 gene in embryonic stem cells results in a block in visceral endoderm differentiation in vitro. In an attempt to elucidate the role of GATA-4 in the formation of visceral endoderm, we have now differentiated Gata4 -/-and wild type embryoid bodies in the presence of retinoic acid + dbcAMP, known inducers of endoderm formation. We show that differentiation of Gata4 -/-embryoid bodies in the presence of retinoic acid results in formation of visceral endoderm, while differentiation of Gata4 -/-embryoid bodies in the presence of retinoic acid plus dbcAMP causes parietal endoderm formation. The presence of these yolk sac endoderm layers was confirmed by light microscopy and analysis of biochemical markers including a-fetoprotein, type IV collagen, laminin, and binding sites for Dolichos biflorus agglutinin. Treatment of Gata4 -I-embryoid bodies with retinoic acid induces expression of another GATA-binding protein, GATA-6, in both visceral and parietal endoderm ceils. That another GATA-binding protein is induced in the absence of GATA-4 suggests that this family of transcription factors plays an important role in yolk sac differentiation. © 1997 Elsevier Science Ireland Ltd.
I. Introduction
The yolk sac plays an essential role in early mouse development (Brent et al., 1990; Jollie, 1990) . Prior to formation of the chorioallantoic placenta, the yolk sac is solely responsible for uptake and transport of nutrients from the maternal circulation to the developing embryo (Cross et al., 1994) . Two specialized types of endodermal cells within the yolk sac, parietal and visceral endoderm cells, facilitate nutrient uptake (Gardner, 1983) . These endodermal cell types are derived from a common precursor, primitive endoderm, which transiently appears along the blastocoelic surface of the day 4 mouse embryo (Gardner, 1983; Hogan et al., 1994) . Parietal endoderm develops in close association with trophectoderm (Hogan and Tilly, 1981) . Parietal endoderm cells synthesize large amounts of type IV collagen and laminin, which are assembled into a specialized basement membrane known as Reichert's membrane that passively filters nutrients and forms a barrier between the maternal and embryonic systems (Gardner, 1983) . Visceral endoderm cells, which develop in association with the inner cell mass, resemble gut enterocytes in appearance and function (Gardner, 1983) . Visceral endoderm cells have apical tight junctions, microvilli, and active endocytic machinery to aid in nutrient uptake. These cells synthesize a-fetoprotein (AFP), transferrin, apolipoproteins, and other proteins involved in nutrient and mineral transport across the basolateral surfaces of these cells.
The regulation of yolk sac endoderm differentiation has been extensively studied over the past two decades. Much of what is known about the mechanisms underlying this process has emerged through in vitro studies of differentiating embryonal carcinoma (EC) cell lines (Darrow et al., 1990) .
When aggregated in the presence of retinoic acid (RA), many EC lines differentiate into visceral endoderm, while stimulation with retinoic acid plus dibutyryl-cAMP (RM dbcAMP) results in parietal endoderm formation (Darrow et al., 1990; Gudas, 1990) . Another group of cell lines useful for in vitro studies of visceral endoderm differentiation are embryonic stem (ES) cells (Doetschman et al., 1985; Wang et al., 1992; Guimaraes et al., 1995; Bautch et al., 1996) . In suspension culture, ES cells spontaneously form embryoid bodies, cell aggregates composed of a variety of differentiated cell types. The in vitro differentiation of ES cells into embryoid bodies recapitulates aspects of normal embryogenesis (Doetschman et al., 1985) . Among the tissue types formed during embryoid body differentiation is visceral yolk sac endoderm, which covers the surface of these bodies. Most ES cell lines do not spontaneously differentiate into parietal endoderm cells, although formation of this cell type can be induced by treatment with RA/dbcAMP (Adamson and Grover, 1983; Grabel et al., 1983; Sherman et al., 1983; Coucouvanis and Martin, 1995) .
One factor that has been implicated in the regulation of yolk sac endoderm differentiation in EC and ES cells is transcription factor GATA-4, a member of a family of zinc finger proteins involved in lineage commitment (Laverriere et al., 1994) . GATA-4 is upregulated during RA-induced differentiation of F9 EC cells into visceral or parietal endoderm (Arceci et al., 1993; Bielinska and Wilson, 1995) and during spontaneous in vitro differentiation of ES cells in visceral endoderm (Soudais et al., 1995) . Recently we demonstrated that targeted mutagenesis in ES cells of both copies of the gene encoding GATA-4 results in a block in visceral endoderm formation during in vitro differentiation into embryoid bodies (Soudais et al., 1995) . Biochemical markers of visceral endoderm, such as AFP, the transcription factor hepatocyte nuclear factor-4 (HNF-4) (Duncan et al., 1994; Taraviras et al., 1995) , and binding sites for Dolichos biflorus agglutinin (DBA), were found to be absent from Gata4 -/-embryoid bodies. We observed this phenotype in independently selected homozygous deficient ES cell lines, suggesting that it was not an artifact of clonal variation. Many other aspects of differentiation appeared unperturbed in the mutant embryoid bodies. On the basis of these observations we concluded that, under in vitro conditions, GATA-4 is essential for visceral endoderm formation, presumably because this transcription factor regulates the expression of genes critical for endoderm differentiation . Here we present evidence that GATA-4-deficient embryoid bodies can develop an external layer of visceral or parietal endoderm when grown in the presence of RA or RMdbcAMP, respectively. Thus, the defect in yolk sac endoderm differentiation manifest in Gata4 -/-embryoid bodies can be circumvented by RA. Another GATA-binding protein, GATA-6, is abundantly expressed in the endoderm layer of RA-treated Gata4 -/-embryoid bodies, suggesting that GATA-6 may substitute for GATA-4 in the extraembryonic endoderm of these bodies.
Results

Morphological changes in Gata4 -/-embryoid bodies treated with RA or RA/dbcAMP
Previous studies with a variety of EC and ES cell lines have shown that aggregation in the presence of RA promotes visceral endoderm differentiation, while treatment with RA/dbcAMP induces parietal endoderm formation (Darrow et al., 1990 ). Earlier we demonstrated that embryoid bodies derived from GATA-4-deficient ES cells do not form a visceral endoderm layer when spontaneously differentiated in suspension culture (Soudais et al., 1995) . In an effort to establish whether the presence of GATA-4 is essential for the development of extraembryonic endoderm lineages, we compared the differentiation of wild type and Gata4 -/-ES cells in the presence of RA alone or in combination with dbcAMP. In agreement with our earlier results (Soudais et al., 1995) , we found that wild type embryoid bodies were covered with a surface layer of visceral endoderm, a thick, densely-stained epithelium with apical vacuoles (Fig. 1A) , but no yolk sac endoderm was evident on the surface of Gata4 -/-embryoid bodies differentiated in the absence of RA (Fig. 1D) . Addition of RA to wild type embryoid bodies did not change significantly the appearance of the surface visceral endoderm (Fig. 1B) . However, the addition of RA to Gata4 -I-embryoid bodies produced a notable change in morphology: RA-treated Gata4 -/-embryoid bodies were covered by an epithelium with the hallmark features of visceral endoderm (Fig. 1E ). This finding suggested that the block in visceral endoderm differentiation exhibited by the mutant embryoid bodies could be overcome by RA treatment. Addition of RMdbcAMP to wild type embryoid bodies resulted in formation of surface epithelium composed of rounded cells with a thick basement membrane characteristic of parietal endoderm (Fig.  1C) . In an analogous fashion, RA/dbcAMP treatment of Gata4 -/-cells induced morphological changes characteristic of parietal endoderm (Fig. 1F) . These RA-and RM To confirm that the morphological changes induced in embryoid bodies by RA or RMdbcAMP reflected the actual formation of visceral or parietal endoderm, we examined a series of biological markers normally expressed on these endoderm layers. One class of markers useful for documenting the presence of yolk sac endoderm are developmentally regulated surface oligosaccharides, which can be detected with monoclonal antibodies or lectins. One such lectin, DBA, recognizes a subset of GalNAc-containing oligosaccharides present on visceral and parietal endoderm but not on undifferentiated cell types (Sato and Muramatsu, 1985) . We examined the ability of this lectin to bind to the surface of 10 day old wild type and GATA-4 homozygous deficient embryoid bodies. Day 10 wild type embryoid bodies exhibited either uniform or patchy FITC-DBA staining ( Fig. 2A) , while visceral endoderm-deficient Gata4 -/ -embryoid bodies displayed no staining (Fig. 2D ). Addition of RA or RA/dbcAMP to Gata4 -/ -embryoid bodies induced expression of binding sites for DBA, consistent with formation of visceral and parietal endoderm (Fig. 2E,F) .
We extended the marker analysis by examining a series of proteins normally expressed in visceral and parietal endoderm. Culture supernatants from metabolically labelled wild type or Gata4 -/ -embryoid bodies at day 7, 10, or 13 of differentiation were subjected to immunoprecipitation with antibody reacting with AFP, a marker of visceral endoderm (Gardner, 1983) (Fig. 3 ). Culture supernatants of wild type embryoid bodies contained little or no [35S]AFP at 7 days of differentiation, but abundant [35S]AFP was detected at 10 and 13 days of differentiation. In RA-treated wild type embryoid bodies, immunoprecipitable [35S]AFP was evident in culture supernatants earlier than in untreated cells (7 versus 10 days of differentiation), suggesting that RA affects the temporal expression of this visceral endoderm marker in wild type embryoid bodies. In agreement with our earlier report (Soudais et al., 1995) , no significant amount of [35S]AFP was expressed by untreated Gata4 -I -embryoid bodies at 7, 10, or 13 days of differentiation. In RA-treated Gata4 -/ -embryoid bodies, [35S]AFP synthesis was detectable as early as day 7 of differentiation and persisted through day 13 of differentiation, consistent with formation of visceral endoderm. Treatment of wild type embryoid bodies with RA/dbcAMP induced expression of a high molecular weight protein recognized by anti-AFP antibody, presumed to be type IV collagen based on an earlier report showing cross-reactivity between anti-AFP IgG and this extracellular matrix protein . In addition to the immunoprecipitation studies, we performed Western blotting on sonicated, detergent-extracted wild type or Gata4 -/ -embryoid bodies using antibodies directed against laminin or type IV collagen (Fig. 4) . RMdbcAMP treatment of either wild type or Gata4 -/ -embryoid bodies induced expression of both laminin and type IV collagen, consistent with formation of parietal endoderm.
Taken collectively, these data confirm that although GATA-4-deficient embryoid bodies do not spontaneously differentiate into visceral endoderm, treatment with RA can induce extraembryonic endoderm in the absence of GATA-4.
Gel shift analysis of GATA-binding proteins in GATA-4-deficient embryoid bodies
These findings led us to question the mechanisms by . Western blot analysis of type IV collagen and laminin in wild type (WT) and Gata4 -/-(MUT) embryoid bodies. The embryoid bodies were grown for the indicated lengths of time, harvested, and subjected to Western blot analysis using antibodies against type IV collagen or laminin.
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which visceral and parietal endoderm layers are established in GATA-4 deficient embryoid bodies after treatment with RA or RA/dbcAMP. It is conceivable that certain target genes for GATA-4 in endoderm might be directly activated via RA response elements (Boylan et al., 1995; Boylan et al., 1993) , bypassing a need for GATA-4. As an alternative explanation we considered the possibility that another GATA-binding protein might be compensating for the absence of GATA-4 in RA-treated embryoid bodies. Such a compensatory response among GATA-binding proteins has been described in GATA-1 deficient embryoid bodies, which display increased expression of GATA-2 during hematopoietic differentiation (Weiss et al., 1994) . To address this latter possibility, we examined whether other GATA-binding proteins were present in the endoderm layer of GATA-4-deficient embryoid bodies. As a first step, we used gel shift analysis to survey for the presence of GATA-binding protein activity in nuclear extracts from embryoid bodies grown in the presence or absence of RA/ dbcAMP. A radiolabelled, double-stranded oligonucleotide probe containing a single GATA consensus motif was used in these studies. We chose RA/dbcAMP-treated embryoid bodies over RA-treated ones as the source of nuclear extracts based on the observation that a higher percentage of the cells in these bodies were endoderm cells. It has been shown that mammalian GATA-binding proteins, all of which are ~50 kDa in size, exhibit similar mobilities in gel shift assays (Arceci et al., 1993; Bielinska and Wilson, 1995) . We therefore employed a polyclonal antibody directed against GATA-4 to discriminate protein-DNA complexes containing GATA-4 from complexes comprised of other GATA-binding proteins. Previous studies have established that this antibody does not recognize GATA-1, -2, or -3 (Arceci et al., 1993; Bielinska and Wilson, 1995) and shows only partial cross-reactivity with GATA-6 in gel shift assays (Morrisey et al., 1996) .
As shown in Fig. 5 , nuclear extract derived from 9 day old Gata4 -/ -embryoid bodies grown in the absence of R M dbcAMP contained little detectable GATA-binding activity (lane 1), whereas nuclear extract derived from RA/ dbcAMP-treated Gata4 -/ -embryoid bodies contained abundant GATA-binding protein activity (lane 4). Addition of anti-GATA-4 antibody did not supershift this protein-DNA complex, although in some experiments a decrease in the intensity of this complex was noted (lane 6). Nor was a supershift observed when monoclonal antibodies against GATA-1, GATA-2, or GATA-3 were added to the binding reactions (data not shown). The decrease in band intensity seen with anti-GATA-4 IgG may be due to the amount of antibody in the binding reaction, since we observed a similar decrease when increasing amounts of anti-GATA-1 antibody were added to control binding reactions (data not shown). When nuclear extracts from wildtype embryoid bodies grown in the absence (lanes 7-9) or (lanes 1-6) , wild type (lanes 7-12), and F9 (lanes 13-15) cell embryoid bodies grown in the absence (lanes 1-3, 7-9) or presence (lanes 4--6, 10-15) of RA/dbcAMP. The 32p-labelled probe used contained a single consensus GATA-motif. The migration of GATA-binding protein-DNA complexes is indicated. Excess unlabelled probe was added to some samples (lanes 2, 5, 8, 11, 14) to verify that binding was specific. Polyclonal antibody recognizing GATA-4 was added to the indicated samples (lanes 3, 6, 9, 12, 15) to supershift complexes containing GATA-4. presence of RA/dbcAMP (lanes 10-12) were used in gel shift assays, we observed protein-DNA complexes which were supershifted by anti-GATA-4 IgG (lanes 9 and 12). An identical supershift was observed with nuclear extract from the RA/dbcAMP-treated F9 cells in 5 day monolayer cultures (lane 15). On the basis of this experiment we conclude that GATA-4 is the predominant GATA-binding protein in extracts of untreated and RAJdbcAMP-treated wild type embryoid bodies. Furthermore, RA/dbcAMP treatment of these embryoid bodies induces high level expression of one or more GATA-binding proteins antigenically distinct from GATA-4.
GATA-6 expression in extraembryonic endoderm
Among members of the GATA-binding family of transcription factors, GATA-4 and GATA-6 exhibit similar tissue distributions and developmental expression patterns, including expression in yolk sac endoderm (Arceci et al., 1993; Heikinheimo et al., 1994; Laverriere et al., 1994; Morrisey et al., 1996; Narita et al., 1996) . We therefore postulated that GATA-6 might be the GATA-binding factor present in the RA-treated Gata4 -/ -embryoid bodies. To see whether GATA-6 was induced during differentiation of ES cells, we performed RNase protection assays on wild type or Gata4 -/ -embryoid bodies grown in the absence or presence of RA. In unstimulated wild type embryoid bodies, GATA-4 and GATA-6 transcripts first appeared after 4 days of differentiation (Fig. 6) . Addition of RA to wild type embryoid bodies altered the time course of expression of these transcripts; GATA-4 and GATA-6 were detected as early as day 2 of differentiation in RA-treated embryoid bodies. In Gata4 -/ -embryoid bodies grown in the absence of RA, abundant GATA-6 mRNA was expressed on day 4 of differentiation. As with wild type embryoid bodies, RA stimulation of Gata4 -/ -embryoid bodies resulted in earlier GATA-6 expression. At early time points of differentiation, the level of GATA-6 mRNA in Gata4 -I -embryoid bodies is much higher than at analogous times in wild type embryoid bodies. RNase protection assays of F9 embryoid bodies differentiated in the presence
F9
GATA-4 GATA-6 Fig. 9 . In situ hybridization of GATA-4 (A-C) and GATA-6 (D-F) transcripts in F9 cell derived embryoid bodies. F9 cell aggregates were grown for 9 days in the presence of either no additives (A,D), RA (B,E), or RA/ dbeAMP (C,F). Note that both GATA-4 and GATA-6 transcripts are expressed in RA-induced surface endoderm. of RA or RA/dbcAMP confirmed that in both instances abundant GATA-6 message was expressed in parallel to GATA-4 message (data not shown).
To determine the distribution of GATA-4 and GATA-6 transcripts within differentiating embryoid bodies, we performed in situ hybridization on wild type and Gata4 -/ -ES cell-derived embryoid bodies grown for either 2 or 10 days in the presence or absence of RA. Consistent with our RNase protection findings, in situ hybridization revealed that on day 2 of differentiation neither wild type nor mutant embryoid bodies grown in the absence of RA expressed a significant amount of GATA-4 (Fig. 7A,C) or GATA-6 (Fig. 7E,G) message. When RA was included in the culture media, both GATA-4 (Fig. 7B ) and GATA-6 (Fig. 7F) transcripts were detected in day 2 wild type embryoid bodies. As expected, no GATA-4 message was observed in day 2 Gata4 -/ -embryoid bodies, even in the presence of RA (Fig. 7D) . However, significant expression of GATA-6 message was observed on the surface of RA-treated Gata4 -/ -embryoid bodies at day 2 of differentiation ( Fig. 7H) . After 10 days of spontaneous differentiation GATA-4 message was confined mostly to visceral endoderm cells in the wild type embryoid bodies (Fig. 8A) , while GATA-6 mRNA was associated with non-endodermal cells in the interior of the wild type embryoid bodies (Fig. 8D) . Treatment of wild type embryoid bodies with RA resulted in a shift in GATA-6 InRNA expression to the visceral endoderm layer (Fig. BE) . This change in distribution of GATA-6 mRNA suggests that RA alters the differentiation program within embryoid bodies; treatment with RA or RA/dbcAMP favors endoderm formation, presumably at the expense of other lineages, and expression of both GATA-4 and GATA-6 transcripts is restricted to the surface endoderm layer. As expected, no GATA-4 message was visible in untreated Gata4 -/-embryoid bodies at day 10 of differentiation ( Fig. 9A) , and GATA-6 mRNA was diffusely expressed throughout these same embryoid bodies (Fig. 9D) . As with wild type embryoid bodies, GATA-6 message in Gata4 -/-embryoid bodies was found predominantly in the visceral endoderm layer after day 10 of RA induction (Fig. 8E) . GATA-6 expression was also induced in the parietal endoderm cells after RA/dbcAMP treatment in both wild type (Fig. 8F) and Gata4 -/-embryoid bodies (Fig.  9F) . The presence of GATA-6 in both visceral and parietal endoderm was also confirmed by in situ hybridization of F9 embryoid bodies grown in the presence of RA or RA/ dbcAMP (Fig. 10) .
In summary, these RNase protection and in situ hybridization results show that GATA-6, like GATA-4, is expressed during RA-induced differentiation into parietal and visceral endoderm. In wild type embryoid bodies, GATA-4 is the major GATA-binding protein expressed in visceral endoderm, both in the absence and presence of RA. In Gata4 -/-embryoid bodies, grown either in the absence or presence of RA, there is increased expression of GATA-6 message in the surface endoderm. The increased expression of GATA-6 in endoderm of Gata4 -/-embryoid bodies lends support to the notion that GATA-binding transcription factors are required for the proper development of visceral and parietal endoderm. On the basis of these findings we suggestthat GATA-6 or a closely related factor may substitute for GATA-4 in the stimulation of certain genes in the endoderm differentiation program.
Discussion
Wild type embryoid bodies grown in suspension culture develop a morphologically recognizable surface visceral endoderm layer, which expresses biochemical markers found in murine yolk sac endoderm. One such marker is transcription factor GATA-4, which is expressed in both the visceral and parietal endoderm layers of the early mouse embryo, as well as the visceral and parietal endoderm of F9 embryonal carcinoma cells differentiated in the presence of RA or RA/dbcAMP (Arceci et al., 1993) . Embryoid bodies derived from Gata4 -/-ES cells display severely compromised visceral endoderm formation (Soudais et al., 1995) , suggesting that transcription factor GATA-4 is crucial for the development of the visceral endoderm lineage in vitro.
The present study was undertaken to establish whether GATA-4 is necessary for yolk sac endoderm differentiation. Here we have shown that both visceral and parietal endoderm can form in GATA-4-deficient embryoid bodies when RA alone or RA/dbcAMP is included in the culture media. The endoderm layers in these RA-treated Gata4 -/-embryoid bodies morphologically resemble murine yolk sac and express many of the characteristic yolk sac endoderm markers. We conclude that both of these yolk sac endoderm lineages can develop in the absence of GATA-4, given the proper stimulation.
Why visceral endoderm differentiation is disrupted in unstimulated Gata4 -/-embryoid bodies but not in RAtreated embryoid bodies has not been fully elucidated. However, a possible explanation is suggested by the pattern of GATA-6 expression in wild type and mutant embryoid bodies. Transcription factor GATA-6 is closely related to GATA-4 in structure, distribution, binding specificity, and proposed function (Laverriere et al., 1994; Jiang and Evans, 1996; Morrisey et al., 1996; Narita et al., 1996) . Previous studies have documented that GATA-4 and GATA-6 are coexpressed in a variety of tissues, including parietal endoderm, myocardium, and gut epithelium (Laverriere et al., 1994; Morrisey et al., 1996; Narita et al., 1996) . The overlapping distributions of GATA-4 and GATA-6 transcripts in the yolk sac, heart, and gut support the possibility of functional redundancy or interplay between these two transcription factors in these tissues, reminiscent of the relationship between the erythroid transcription factors GATA-1 and GATA-2. Targeted disruption of the Gatal gene is associated with an increase in expression of GATA-2 mRNA in differentiating erythroid cells, perhaps reflecting a compensatory response (Weiss et al., 1994) . Additional support for the notion of genetic redundancy comes from studies with Xenopus embryos, showing that ectopic expression of either GATA-4 or GATA-6 is associated with transient activation of cardiac genes (Jiang and Evans, 1996) . We propose that a similar situation may hold true for yolk sac endoderm lineages. In wild type embryoid bodies, GATA-4 is the predominant GATA-binding protein expressed in visceral endoderm, both in the absence and presence of RA. In Gata4 -/-embryoid bodies grown either in the absence or presence of RA, there is increased expression of GATA-6 message, especially in the surface endoderm. Based on these studies, we favor the notion that the defect in visceral endoderm differentiation evident in the unstimulated Gata4 -/-embryoid bodies is due to a lack of activation of certain target genes by GATA-4, and that stimulation with RA circumvents this defect either by directly activating these same target genes or by inducing expression of other GATA-binding transcription factors, such as GATA-6. The identity of these target genes in endoderm has not been established, although a number of extracellular matrix genes contain GATA-binding sites and RA response elements (reviewed in Wang, 1994; Bielinska and Wilson, 1995) . Formal proof that GATA-6 or some other GATAbinding protein can substitute for GATA-4 in yolk sac differentiation awaits additional genetic tests, including characterization of GATA-6 knockout cells.
Recently, in situ hybridization analysis showed that GATA-6 is expressed in parietal and not in the visceral endoderm of the mouse embryo (Morrisey et al., 1996) . It is evident from our in situ hybridization data that in sponta-neously differentiating wild type embryoid bodies GATA-6 mRNA is localized to the ceils occupying the center of the embryoid bodies, and this distribution changes to the cells at the embryoid body surface in the presence of RA. Similarly, GATA-6 message is expressed on the surface of the GATA-4-deficient embryoid bodies and F9 cell-derived embryoid bodies differentiated in the presence of RA. Thus, these data suggest that GATA-6 is RA-inducible in the yolk sac endoderm lineages. However, the lack of GATA-6 mRNA in the visceral endoderm in the embryo and in the 10 day old wild type embryoid body visceral endoderm layer suggests that GATA-6 may not be expressed during all stages of visceral endoderm development, especially if GATA-4 is concomitantly expressed. In the case of GATA-4-deficient embryoid bodies, GATA-6 may substitute for GATA-4 in differentiation of the visceral endoderm phenotype but only in the presence of RA.
It is not known if the GATA-4 or GATA-6 promoters contain RA response elements or whether these promoters are directly activated by RA. It appears that the effect of RA on GATA-4 and GATA-6 expression is tissue-specific. There is no increase in the expression of either of these factors when P19 EC are cells grown in the presence of RA, while during DMSO-induced cardiac differentiation of P19 embryoid bodies both GATA-4 and GATA-6 mRNAs are elevated (Gr@in et al., 1995 and unpublished observations) .
In summary, we have shown that RA can circumvent the block in visceral endoderm development in Gata4 -/-embryoid bodies. Comparison of surface expression of several visceral endoderm markers in RA-treated embryoid bodies with the expression on the surface of spontaneously differentiated wild type embryoid bodies suggests that RAinduced differentiation resembles the early stages of visceral endoderm development in which the other GATA-binding factors, namely GATA-6, may compensate for the absence of GATA-4.
were usually split into two plates after 5-6 days of culture. F9 EC cells were obtained from the American Type Tissue Collection and were maintained in culture as described elsewhere (Darrow et al., 1990 ). To induce visceral or parietal endoderm differentiation, 5 × 10 -8 M RA or the combination of 3 x 10 -7 M RA plus 1 mM dbcAMP were included into the F9 culture media.
Light microscopy of embryoid bodies
Embryoid bodies were washed with serum-free medium, fixed >2 h in Kamovsky's solution, post-fixed with OSO4, and embedded in Spurr epoxy resin. One #m sections were stained with hematoxylin-eosin (H and E) and viewed under light microscopy (Soudais et al., 1995) .
Metabolic labelling and immunoprecipitation
Embryoid bodies derived from wild type and homozygous deficient cells were incubated in six-well dishes for 18 h in 1.5 ml of cysteine-and methionine-free DME supplemented with 50 #Ci/ml tranaSS-label (ICN). Samples of conditioned media were then harvested and centrifuged at 11 000 × g to remove debris. The resultant supernatant fractions were mixed with 0.1 vol. of a 10 x concentrate of NET-gel immunoprecipitation buffer (Sambrook et al., 1989) . Equal quantities of TCA precipitable counts (approximately 9 × 105 CPM) were incubated for 1 h at room temperature with a 1:250 dilution of rabbit antimouse AFP (ICN) followed by a 1 h incubation at room temperature with 20 /A of protein A-agarose beads. The beads were harvested by centrifugation, washed extensively (Sambrook et al., 1989) , and then boiled in SDS-sample buffer (Laemmli, 1970) . Eluted proteins were separated by SDS-PAGE on a 10% gel and then identified by fluorography after soaking the gel in 1 M sodium salicylate.
Western blotting of embryoid bodies
Methods
Culture of ES and F9 cells
The preparation and initial characterization of Gata4 -/-ES cells is described elsewhere (Soudais et al., 1995) . To generate embryoid bodies, single cell suspensions of 106 wild type or Gata4 -/-ES cells were seeded into bacterial l0 cm Petri dishes in 10 ml DME media containing 10% fetal calf serum, 10% newborn calf serum, 0.1 mM 2-mercaptoethanol, 50 U/ml penicillin/streptomycin, 0.1 mM non-essential amino acids and 2 mM L-glutamine. To induce visceral or parietal endoderm differentiation, 5 x 10 -8 M RA or the combination of 3 x 10 -7 M RA plus 1 mM dbcAMP were included into culture media. Media were replaced with fresh media after the first 3 days of culture and subsequently every other day. Embryoid bodies Embryoid bodies from wild type and Gata4 -/-ES cells were washed twice with PBS and then lysed by sonication in NET buffer (Sambrook et al., 1989) supplemented with 80 /~g/ml PMSF, 0.4% aprotinin, 2 #g/ml leupeptin, and 2/zg/ ml pepstatin. The samples were centrifuged at 11 000 x g and the resultant supernatants collected. Protein concentrations were determined using Bradford reagent (BioRad) and 10-20 /~g samples of soluble protein were subjected to SDS-PAGE and then electrophoretically transferred to nitrocellulose membranes. Western blotting was performed as described (Harlow and Lane, 1988) , using a 1:500 dilution of rabbit anti-mouse laminin (Collaborative Biomedical Products, Bedford, MA) or a 1:300 dilution of rabbit antimouse type IV collagen (Chemicon International Inc., Temecula, CA). Bound antibody was detected with the ECL (Amersham) system using 1:10 000 dilution of the secondary antibody.
Lectin staining of embryoid bodies
Wild type and homozygous deficient embryoid bodies were fixed for 10 min at room temperature in 2% glutaraldehyde, washed, and then stained for 30 min at room temperature with 0.5 mg/ml FITC-labelled DBA (Sigma), as described elsewhere (Sato and Muramatsu, 1985) . The cells were then washed twice in PBS and photographed using an inverted fluorescent microscope.
In situ hybridization
Embryoid bodies were washed in PBS, fixed for 15 min in 4% paraformaldehyde in PBS, rinsed in PBS containing 10% sucrose, and frozen in OCT cryopreservation solution (Tissue-Tek). Ten t~m sections were subjected to in situ hybridization using [33p]UTP (1000-3000 Ci/rnmol, Amersham)-labelled antisense riboprobes (Narita et al., 1996) . The following plasmids, restriction enzymes and polymerases were used to generate the riboprobes: GATA-4, pBluescript clone ~G14A (Arceci et al., 1993) , BamHI, T7; GATA-6, pCRII subclone, EcoRV, Sp6 (Narita et al., 1996) .
Z Gel shift analysis
Nuclear extracts were prepared (Andrews and Failer, 1991) from 9 day old GATA-4-deficient and wild type embryoid bodies grown in the presence and absence of RA/dbcAMP or F9 EC cells differentiated for 5 days in monolayer culture in the presence of RA/dbcAMP. A double-stranded oligonucleotide based on the portion of human preproendothelin-1 (PPET-1) promoter containing a single GATA-binding site in the following sequence, TGG-CCTFATCTCCGG, was end-labelled with [3,-32p]-ATP (Wilson et al., 1990) . Gel shift and supershift analyses were performed as described using 20/~g of nuclear extract protein and a polyclonal anti-GATA-4 antibody (Arceci et al., 1993) .
RNase protection assays
RNase protection assays were performed using a commercially available kit (Ambion) and 10/zg of total RNA. 32p-Riboprobes were prepared as described elsewhere (Soudais et al., 1995) . The following plasmids, restriction enzymes, and polymerases were used to generate riboprobes: GATA-4, pBluescript clone )~G14A (Arceci et al., 1993) , NotI, T7; GATA-6, pCRII subclone (Narita et al., 1996) , PstI, SP6. A control/3-actin riboprobe was prepared as per the manufacturer's directions.
